Using oral amiodarone safely

Drug and Therapeutics Bulletin

Volumn 41, Issue 2, 2003, Pages 9-12

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTITHYROID AGENT; CARBIMAZOLE; CORTICOSTEROID; CYCLOSPORIN; CYTOCHROME P450 3A4; DIGOXIN; DISOPYRAMIDE; FLECAINIDE; LIOTHYRONINE; PHENYTOIN; PREDNISOLONE; PROPAFENONE; PROPYLTHIOURACIL; QUINIDINE; SOTALOL; THYROTROPIN; VERAPAMIL; WARFARIN;

ARTICLE; ATAXIA; BRONCHIOLITIS; CARDIOTOXICITY; CLINICAL TRIAL; COUGHING; DEFIBRILLATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG SAFETY; DYSPNEA; HEART ARRHYTHMIA; HOSPITAL CARE; HUMAN; HYPERTHYROIDISM; HYPOKALEMIA; HYPOTHYROIDISM; INTERSTITIAL PNEUMONIA; LICENCE; LIVER TOXICITY; LONG TERM CARE; LUNG TOXICITY; MAINTENANCE THERAPY; MEDICAL SPECIALIST; NEUROTOXICITY; PATIENT MONITORING; PERIPHERAL NEUROPATHY; PRESCRIPTION; RESPONSIBILITY; SKIN TOXICITY; THYROIDITIS; TREATMENT FAILURE; TREMOR; VISUAL IMPAIRMENT;

EID: 0037297588     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: 10.1136/dtb.2003.4129     Document Type: Article

References (18)

1. Latini R et al. Clinical pharmacokinetics of amiodarone. Clin Pharmacokinet 1984; 9: 136-56.
2. Daoud EG et al. Preoperative amiodaronte as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 1997; 337: 1785-91.
3. Giri S et al. Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial. Lancet 2001; 357: 830-6.
4. Vitolo E et al. Amiodarone versus quinidine in the prophylaxis of atrial fibrillation. Acta Cardiol 1981; 36: 431-44.
5. Roy D et al for the Canadian Trial of Atrial Fibrillation Investigators. Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med 2000; 342: 913-20.
6. Kochiadakis GE et al. Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled study. Heart 2000; 84: 251-7.
7. Fuser V et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (committee to develop guidelines for the management of patients with atrial fibrilation). Developed in collaboration with the North American Society of Pacing and Electrophysiology. Circulation 2001; 104: 2118-50.
8. Amiodarone Trials Meta-Analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Lancet 1997; 350: 1417-24.
9. Connoly SJ et al. on behalf of the AVID, CASH and CIDS studies. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. Eur Heart J 2000; 21: 2071-8.
10. National Institute for Clinical Excellence, 2000. Guidance on the use of implantable cardioverter defibrillators for arrhythmias. Technology appraisal guidance no. 11. [online]. Available from: http://www.nice.org.uk/article.asp?a=17249 [Accessed 27 January 2003].
11. Vorperian VR et al. Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol 1997; 30: 791-8.
12. Committee on Safety of Medicines. Amiordarone (Cardarone X). Curr Probl Pharmacovigilance 1996; 22: 3-4.
13. Jessurun GA et al. Amiodarone-induced pulmonary toxicity. Predisposing factors, clinical symptoms and treatment. Drug Saf 1998; 18: 339-44.
14. Martino E et al. The effects of amiodarone on the thyroid. Endocr Rev 2001; 22:240-54.
15. Loh K-C. Amiodarone-induced throid disorders: a clinical review. Postgard Med J 2000; 76: 597-8.
16. Newman CM et al. Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy. Heart 1998; 79: 121-7.
17. Hohnloser SH et al. Amiodarone-associated proarrhytmic effects. A review with special reference to torsade de pointes tachycardia. Ann Intern Med 1994; 121: 529-35.
18. Harris L et al. Side effects of long-term amiodarone therapy-Circulation 1983; 67: 45-51.